Yasuo Iwamoto

6.0k total citations
68 papers, 1.8k citations indexed

About

Yasuo Iwamoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yasuo Iwamoto has authored 68 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Yasuo Iwamoto's work include Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Diagnosis and Treatment (24 papers) and Lung Cancer Research Studies (18 papers). Yasuo Iwamoto is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Diagnosis and Treatment (24 papers) and Lung Cancer Research Studies (18 papers). Yasuo Iwamoto collaborates with scholars based in Japan, United Kingdom and India. Yasuo Iwamoto's co-authors include Teruomi Miyazawa, Yuka Miyazu, Noriaki Kurimoto, Koji Kanoh, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Nobuoki Kohno, Toshiyuki Sawa, Koji Takeda and Takashi Seto and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Cancer.

In The Last Decade

Yasuo Iwamoto

67 papers receiving 1.7k citations

Peers

Yasuo Iwamoto

PRM

ONCOL

SURGE

PFM

Yusuke Onozawa Japan

Shinzo Takamori Japan

Harry Raftopoulos United States

Óscar Juan Spain

Amir Abolhoda United States

Felix Chu United States

Takahiro Tsushima Japan

Motohiro Tamiya Japan

Sook Whan Sung South Korea

L. Goedhals South Africa

Yusuke Onozawa Japan

Yasuo Iwamoto

902 ×0.8

PRM

718 ×1.0

ONCOL

656 ×1.9

SURGE

239 ×0.7

103 ×0.6

PFM

Citations per year, relative to Yasuo Iwamoto Yasuo Iwamoto (= 1×) peers Yusuke Onozawa

Countries citing papers authored by Yasuo Iwamoto

Since Specialization

Citations

This map shows the geographic impact of Yasuo Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Iwamoto more than expected).

Fields of papers citing papers by Yasuo Iwamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Iwamoto. The network helps show where Yasuo Iwamoto may publish in the future.

Co-authorship network of co-authors of Yasuo Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Iwamoto. A scholar is included among the top collaborators of Yasuo Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Iwamoto. Yasuo Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kono, Yoshiyasu, Yasuhiro Choda, Masahiro Nakagawa, et al.. (2021). Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab. Targeted Oncology. 16(2). 237–248. 9 indexed citations

Nakashima, Kazuhisa, Hiroaki Akamatsu, Haruyasu Murakami, et al.. (2019). Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung Cancer. Anticancer Research. 39(3). 1463–1468. 4 indexed citations

Fujimori, Takahito, Tadashi Watabe, Yasuo Iwamoto, et al.. (2016). Prevalence, Concomitance, and Distribution of Ossification of the Spinal Ligaments. Spine. 41(21). 1668–1676. 138 indexed citations

Shukuya, Takehito, Takeharu Yamanaka, Takashi Seto, et al.. (2015). Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial. The Lancet Oncology. 16(16). 1630–1638. 65 indexed citations

Horitsugi, Genki, Toshioh Fujibuchi, Ichiro Yamaguchi, et al.. (2012). Radiologic assessment of a self-shield with boron-containing water for a compact medical cyclotron. Radiological Physics and Technology. 5(2). 129–137. 4 indexed citations

Kurata, Takayasu, Tomonori Hirashima, Yasuo Iwamoto, et al.. (2012). A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group Trial (WJTOG) 2905. Lung Cancer. 77(1). 110–115. 1 indexed citations

Saito, Hiroshi, Kazuhiko Nakagawa, Koji Takeda, et al.. (2011). Randomized Phase II Study of Carboplatin-Paclitaxel or Gemcitabine-Vinorelbine in Patients With Advanced Nonsmall Cell Lung Cancer and a Performance Status of 2. American Journal of Clinical Oncology. 35(1). 58–63. 8 indexed citations

Sakata, Yasuhiko, et al.. (2010). Efficacy of Olanzapine against Nausea and Vomiting in Cancer Patients Receiving Chemotherapy. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36(10). 717–722. 1 indexed citations

Kaneda, Hiroyasu, Isamu Okamoto, Hidetoshi Hayashi, et al.. (2010). Phase II Trial of Amrubicin for Second-Line Treatment of Advanced Non-small Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG0401). Journal of Thoracic Oncology. 5(1). 105–109. 15 indexed citations

10.

Kobayashi, Masashi, Kaoru Matsui, Yasuo Iwamoto, et al.. (2010). Phase II Study of Sequential Triplet Chemotherapy, Irinotecan and Cisplatin Followed by Amrubicin, in Patients with Extensive-Stage Small Cell Lung Cancer: West Japan Thoracic Oncology Group Study 0301. Journal of Thoracic Oncology. 5(7). 1075–1080. 11 indexed citations

11.

Nishimura, Takashi, Nobuyuki Katakami, Masashi Kobayashi, et al.. (2007). P3-121: Phase II study of gefitinib as a first–line therapy in elderly patients with lung adenocarcinoma (WJTOG 0402–DI). Journal of Thoracic Oncology. 2(8). S730–S731. 2 indexed citations

12.

Ishida, Atsuko, Teruomi Miyazawa, Yuka Miyazu, et al.. (2006). Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non‐small cell lung cancer. Respirology. 11(1). 90–97. 28 indexed citations

13.

Ishida, Atsuko, Teruomi Miyazawa, Yuka Miyazu, et al.. (2005). MEDICAL THORACOSCOPY USING A FLEXIRIGID THORACOSCOPE IN THE DIAGNOSIS OF PLEURAL EFFUSION OF UNKNOWN CAUSE. CHEST Journal. 128(4). 320S–320S. 3 indexed citations

14.

Miyazawa, Teruomi, Yuka Miyazu, Yasuo Iwamoto, et al.. (2004). Stenting at the Flow-limiting Segment in Tracheobronchial Stenosis due to Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 169(10). 1096–1102. 75 indexed citations

15.

Iwamoto, Yasuo, Teruomi Miyazawa, Noriaki Kurimoto, et al.. (2004). Interventional Bronchoscopy in the Management of Airway Stenosis Due to Tracheobronchial Tuberculosis. CHEST Journal. 126(4). 1344–1352. 83 indexed citations

16.

Taguchi, Fumiko, Hitoshi Kusaba, Akira Asai, et al.. (2003). hnRNP L enhances sensitivity of the cells to KW‐2189. International Journal of Cancer. 108(5). 679–685. 8 indexed citations

17.

Miyazu, Yuka, Teruomi Miyazawa, Noriaki Kurimoto, et al.. (2002). Endobronchial Ultrasonography in the Assessment of Centrally Located Early-Stage Lung Cancer before Photodynamic Therapy. American Journal of Respiratory and Critical Care Medicine. 165(6). 832–837. 114 indexed citations

18.

Fukuoka, Kazuya, Hitoshi Arioka, Yasuo Iwamoto, et al.. (2001). Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells. Lung Cancer. 34(3). 451–460. 42 indexed citations

19.

Iwamoto, Yasuo, Kazuto Nishio, Hisao Fukumoto, et al.. (1998). Preferential Binding of E7010 to Murine β3‐Tubulin and Decreased β3‐Tubulin in E7010‐resistant Cell Lines. Japanese Journal of Cancer Research. 89(9). 954–962. 34 indexed citations

20.

Tomonari, Akira, Kazuto Nishio, Hirokazu Kurokawa, et al.. (1997). Proximal 5′-Flanking Sequence of the Human γ-Glutamylcysteine Synthetase Heavy Subunit Gene Is Involved in Cisplatin-Induced Transcriptional Up-regulation in a Lung Cancer Cell Line SBC-3. Biochemical and Biophysical Research Communications. 236(3). 616–621. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact